029 Group SE

M&A Activity • Jul 19, 2001

News Details

Corporate | 19 July 2001 14:00

Isonics Corp. english

Corporate-News announcement sent by DGAP. The sender is solely responsible for the contents of this announcement. ——————————————————————————– ISONICS ANNOUNCES JOINT DEVELOPMENT PROGRAM WITH ADVANCED MICRO DEVICES GOLDEN, CO (July 18, 2001) Isonics Corporation (NasdaqSC: ISON/ISONW) (OTCBB: ISONL/ISONZ) and (Frankfurt: IO9) a leader in the development of isotopically pure silicon-28 wafers for semiconductor device manufacture has announced that Advanced Micro Devices (NYSE: AMD) was the partner not identified in the previously announced silicon-28 joint development program. James E. Alexander, Isonics President & CEO, commented: Our partner in the recently announced Joint Development Program is AMD. We are pleased that AMD has seen sufficient potential value in high thermal conductivity silicon-28 to commit to a program to help determine the optimum design of silicon-28 wafers which could potentially be used in the manufacture of AMDs future microprocessor products. Under the agreement AMD will share certain performance and yield data with Isonics. AMD has requested that additional details of the program remain confidential. Isonics is a world leader in isotopically engineered materials and produces isotopically pure silicon-28 chemicals and wafers for the semiconductor industry. Isonics also markets and sells stable isotopes for the health care industry such as carbon-13 for diagnostic breath tests and drug design, and oxygen-18 for positron emission tomography (PET) imaging. Stable isotopes can be thought of as ultra pure materials. For additional information visit www.isonics.com. Isonics Corporation Dr. Stephen J. Burden 303-279-7900 Cameron Associates Michael Brod 212-245-8800 michael@cameronassoc.com Except for historical information contained herein, this document contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements involve known and unknown risks and uncertainties that may cause the Companys actual results or outcomes to be materially different from those anticipated and discussed herein. Further, the Company operates in industries where securities values may be volatile and may be influenced by regulatory and other factors beyond the Companys control. Other important factors that the Company believes might cause such differences are discussed in the risk factors detailed in the Companys 10-KSB for the year ended April 30, 2000, and its quarterly report on Form 10-QSB for the nine months ended January 31, 2001, both as filed with the Securities and Exchange Commission, which include the Company’s cash flow difficulties, dependence on significant customers, and rapid development of technology, among other risks. In assessing forward-looking statements contained herein, readers are urged to carefully read all cautionary statements contained in the Companys filings with the Securities and Exchange Commission. end of message, (c) DGAP 19.07.2001